Dec 18, 2009
Flamel Technologies Announces the Initiation of a Phase 2a Clinical Trial of Flamel's IFN-Alpha-2b XL in Patients with Chronic Hepatitis C Virus Infection
Nov 16, 2009
Flamel Technologies Announces Third Quarter 2009 Results; Additional New Projects; Cash Increases from $45.1 to $48.8 million
Nov 04, 2009
Flamel Technologies Announces Licensing Agreement with Pfizer
Nov 04, 2009
Flamel Technologies Announces Projected Release Date of Third Quarter Results; Conference Call
Sep 18, 2009
Flamel Technologies to Present at UBS Global Life Sciences Conference
Aug 05, 2009
Flamel Technologies Announces Second Quarter 2009 Results; Multiple
New Projects; Cash Increases from $39.1 to $45.1 million
Jul 28, 2009
Flamel Technologies Announces Projected Release Date of Second Quarter Results; Conference Call
Jul 13, 2009
Baxter and Flamel Technologies Announce Collaboration to Formulate Longer Acting Forms of Blood Clotting Factors
Jun 25, 2009
Flamel Technologies Announces Results of Annual Meeting
Jun 24, 2009
Flamel Technologies Announces Two New Feasibility Agreements
Jun 22, 2009
Flamel Technologies Announces New Feasibility Projects; Technology Access Fee
May 11, 2009
Flamel Technologies Announces Profitable First Quarter Results; Increased Cash Levels
May 05, 2009
Flamel Technologies Announces Projected Release Date of First Quarter Results;
Conference Call
Mar 20, 2009
Flamel Technologies to Receive $4 Million Milestone Payment from GlaxoSmithKline
Mar 16, 2009
Flamel Technologies to Present at the 29th Annual Cowen and Company Healthcare Conference in Boston
Mar 04, 2009
Flamel Technologies Announces Fourth Quarter and Year-End 2008 Results
Feb 24, 2009
Flamel Technologies Announces Projected Release Date of Fourth Quarter and Annual Results; Conference Call
Feb 23, 2009
Flamel Technologies Announces Appointment of Jeffery S. Vick as Chief Business Officer
Feb 17, 2009
Flamel Technologies Announces Merck Serono's Exercise of Option to License Medusa Technology for Development of an Extended-Release Formulation of a Therapeutic Protein
